MOSCOW (MRC) -- Alpek, the petrochemicals arm of Mexican conglomerate Alfa, reported a loss attributable to controlling interests of USD71mn in the second quarter compared to a profit of USD82mn year-on-year as a result of a USD114mn net impact related to the closure of the Cape Fear site in North Carolina, said Bnamerica.
Excluding the closure, profit attributable to controlling interests amounted to USD43mn for the quarter, Alpek said in a statement.
For the first half the company reported a loss of USD10mn compared to a USD160mn profit in 1H12.
Ebitda declined 39% to US$122mn in the second quarter from USD201mn a year earlier. Year-to-date Ebitda decreased 29% to USD282mn from USD396mn. Excluding the Cape Fear expense provision (USD27mn), Ebitda amounted to USD149mn in the quarter and USD309mn in H2.
Sales in the quarter and half were down 5% year-on-year to USD1.81bn and USD3.64bn, respectively.
Capex for the quarter was USD60mn, increasing 120% year-on-year driven by the ongoing investment in the Cosoleacaque cogeneration plant, which through end-June was more than 80% complete.
Net debt at end-June amounted to USD644mn, unchanged from a year ago but 14% lower than end-March, while gross debt declined by 21% over the period.
As MRC wrotebefore, Alpek reported a profit attributable to controlling interests of USD61mn in the first quarter, down 22% year-on-year as a result of a 23% decrease in operating income, to USD119mn.
Alpek is the largest petrochemical company in Mexico and the second largest in Latin America. The company operates through two business segments: Polyester chain products (PTA, PET and polyester fibers), and Plastics and Chemicals products (PP, EPS, caprolactam, polyurethanes and other specialty and industrial chemicals). Alpek is a leading producer of PTA and PET worldwide, operates the largest expandable polystyrene plant in America and one of the largest polypropylene plants in North America. It is also the only producer of caprolactam in Mexico. In 2012, Alpek reported revenues of USD7,277 million and EBITDA of U.S. USD728 million. The company operates 20 plants in Mexico, USA and Argentina, and employs 4,700 people. Alpek is a publicly traded company listed on the Mexican Stock Exchange.
MRC